Founded in 1995, Acorda Therapeutics is a biotechnology company. It develops and provides various therapies for the restoration of neurological functions. The company specializes in the therapies for spinal cord injury and multiple sclerosis. Acorda s marketed products include Zanaflex capsules, Zanaflex tablets and Fampridine-SR. The company operates through its advisory network of clinical scientists and academicians having expertise in various areas, including pharmacology, molecular and cell biology, clinical neurology, nerve cell death and spinal cord physiology. It has an in-house research and development laboratory for the study of tissue culture methods and predictive animal models of spinal cord injuries and multiple sclerosis. Acorda Therapeutics is headquartered in Hawthorne, N.Y.